What is the safe weight‑based dosing range of dicyclomine for children older than six months (mg per kilogram per dose)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dicyclomine Weight-Based Dosing in Children Over 6 Months

The FDA-approved drug label explicitly contraindicates dicyclomine in infants under 6 months of age, but does not establish a safe weight-based dosing range for children above 6 months 1. The only published pediatric dosing data comes from a single research study that used 3 mg/kg/day in infants aged 3-12 weeks for infantile colic 2.

Critical Safety Considerations

FDA Position

  • Dicyclomine is contraindicated in infants less than 6 months of age due to serious adverse events including respiratory symptoms (dyspnea, respiratory collapse, apnea), seizures, syncope, muscular hypotonia, coma, and death 1
  • Safety and effectiveness in pediatric patients have not been established at any age 1
  • The drug label provides no approved pediatric dosing recommendations for any age group

Published Research Evidence

The only weight-based pediatric dosing data available is from a 1994 study that administered 3 mg/kg/day (divided doses) to infants with severe colic 2. This translates to approximately 0.25-0.5 mg/kg per dose if given 3-4 times daily. However, this study:

  • Included infants as young as 3 weeks (below the FDA contraindication threshold)
  • Was conducted before current safety warnings were established
  • Showed only 53-67% efficacy for colic symptoms

Clinical Recommendation

Given the lack of FDA-approved pediatric dosing, established safety concerns, and absence of proven efficacy data, dicyclomine should not be routinely used in children of any age. If absolutely necessary in children over 6 months despite these concerns, the historical research dose of approximately 0.3-0.5 mg/kg per dose represents the only published reference point, though this lacks regulatory approval or modern safety validation 2.

Key Caveats

  • No maximum dose is established for pediatric patients
  • Renal and hepatic function should be considered, as the drug is substantially renally excreted 1
  • Risk of heat prostration in high environmental temperatures due to decreased sweating 1
  • Drowsiness and blurred vision are common adverse effects 1
  • Intravenous administration must be avoided due to thrombosis risk 3

The approximation of 0.3-0.5 mg/kg per dose mentioned in your question aligns with the only available research data, but this should not be interpreted as an FDA-endorsed or guideline-supported recommendation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.